The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection

Anaesthesia

Volumn 75, Issue 4, 2020, Pages 464-471

  Tai, Y H ^a   Wu, H L ^b   Mandell, M S ^c   Tsou, M Y ^b   Chang, K Y ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

cancer recurrence; hepatectomy; hepatocellular carcinoma

Indexed keywords

ADULT; ALL CAUSE MORTALITY; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL DECISION MAKING; DISEASE FREE SURVIVAL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; SURVIVAL TIME; TREATMENT RESPONSE; LIVER TUMOR; PROCEDURES; TUMOR RECURRENCE;

BLOOD TRANSFUSION; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 85073920057     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14862     Document Type: Article

References (29)

1. World Health Organization International Agency for Research on Cancer. GLOBOCAN: estimated cancer incidence, mortality and prevalence worldwide in 2018. http://gco.iarc.fr/today/fact-sheets-cancers (accessed 22/04/2019).
2. Chan AWH, Zhong J, Berhane S, et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. Journal of Hepatology 2018; 69: 1284–93.
3. Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Annals of Surgery 2015; 261: 947–55.
4. Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. Journal of the American Medical Association Surgery 2018; 154: 209–17.
5. Zou H, Zhu CZ, Wang C, et al. Recurrence of Barcelona clinic liver cancer stage A hepatocellular carcinoma after hepatectomy. American Journal of the Medical Sciences 2017; 354: 262–7.
6. Cescon M, Vetrone G, Grazi GL, et al. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Annals of Surgery 2009; 249: 995–1002.
7. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Archives of Surgery 2012; 147: 49–55.
8. Odell DD, Bilimoria KY. Evaluating appropriate blood transfusion in cancer surgery. Journal of the American Medical Association Surgery 2016; 151: 525–6.
9. Matsumata T, Ikeda Y, Hayashi H, Kamakura T, Taketomi A, Sugimachi K. The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer 1993; 72: 1866–71.
10. Makino Y, Yamanoi A, Kimoto T, El-Assal ON, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. American Journal of Gastroenterology 2000; 95: 1294–300.
11. Liu L, Wang Z, Jiang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS ONE 2013; 8: e64261.
12. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. Journal of Clinical Oncology 2000; 18: 1094–101.
13. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. Journal of Clinical Gastroenterology 2000; 31: 302–8.
14. Abou-Alfa GK, Pawlik SJ, Vauthey JN. Liver. In: Amin MB, ed. AJCC Cancer Staging Manual. Chicago, IL: AJCC, 2017: 191–200.
15. Iguchi T, Aishima S, Taketomi A, et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. American Journal of Surgical Pathology 2008; 32: 1675–82.
16. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Statistics in Medicine 2010; 29: 1037–57.
17. Thoemmes F, Ong AD. A primer on inverse probability of treatment weighting and marginal structural models. Emerging Adulthood 2016; 4: 40–59.
18. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983; 39: 499–503.
19. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Statistics in Medicine 2015; 34: 3661–79.
20. Hill AB. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine 1965; 58: 295–300.
21. Yang T, Lu JH, Lau WY, et al. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: a propensity score matching analysis. Journal of Hepatology 2016; 64: 583–93.
22. Kuroda S, Tashiro H, Kobayashi T, Oshita A, Amano H, Ohdan H. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy. World Journal of Surgery 2012; 36: 651–8.
23. Pirracchio R, Resche-Rigon M, Chevret S. Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size. BMC Medical Research Methodology 2012; 12: 70.
24. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. British Journal of Anaesthesia 2013; 110: 690–701.
25. Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas. Cancer 2001; 91: 771–8.
26. Sugita S, Sasaki A, Iwaki K, et al. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. European Journal of Surgical Oncology 2008; 34: 339–45.
27. Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World Journal of Surgery 2007; 31: 2044–51.
28. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Annals of Surgery 2012; 256: 235–44.
29. Wu HL, Tai YH, Lin SP, Chan MY, Chen HH, Chang KY. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4,030 patients. Scientific Reports 2018; 8: 13345.